March 2018
Blue Cross and BCN will no longer cover Alvesco®
To address the high cost of drugs and provide the best value for our members, Blue Cross Blue Shield of Michigan and Blue Care Network commercial plans will no longer cover Alvesco, starting March 1, 2018. Alvesco is a drug used to treat asthma. If members continue to use Alvesco on or after this date, they will be responsible for the full cost.
There are lower-cost prescription alternatives available. The covered alternatives are listed below.
Not covered beginning March 1, 2018 |
Preferred alternatives that are covered |
Alvesco (member pays full cost) |
Arnuity® Ellipta® |
|
Asmanex®, Asmanex® HFA |
|
Flovent® HFA, Flovent® Diskus® |
|
Pulmicort solution, Pulmicort® Flexhaler® |
|
Qvar® |
|